OP15.07: Use of the cardiovascular resistance index to predict labetalol non‐response in the management of hypertensive crisis during pregnancy

To determine the role of hemodynamic and biophysical markers at hypertensive crisis to predict treatment failure with labetalol. This cohort study involved pregnancies with hypertensive crisis upon admission or during hospitalisation. Heart rate (HR), systolic (SBP), and diastolic blood pressure (DBP) were recorded before IV-labetalol administration. The cardiovascular resistance index (CVRI) was calculated as SBP/HR. Non-responders to labetalol were identified if maximum dose was reached or if a Caesarean section was required due to fetal distress during treatment. A hyperdynamic profile was defined as HR>90 and estimated fetal weight (EFW) >10th percentile. A high-resistance profile was characterised by EFW < 10th percentile or HR< 90. Responders and non-responders were compared using Mann-Whitney test. Time-to-response in both profiles was assessed using Cox regression and Kaplan-Meier curves. Finally, a multivariate logistic regression analysis was conducted to determine factors associated with therapeutic failure with beta-blockers. Out of the 44 pregnancies examined, 57% (n = 25) were identified as non-responders. Responders exhibited a higher incidence of the hyperdynamic profile compared to non-responders (26% vs. 4%; p = 0.03). Additionally, non-responders displayed a significantly higher CVRI compared to responders (2.27 [2.03-2.48] vs. 1.90 [1.47-2.14]; p = 0.002). Time-to-response was markedly shorter in the hyperdynamic profile group compared to the high-resistance profile (p < 0.05). Multivariate analysis revealed that lower gestational age, higher SBP, and lower HR were the most reliable predictors of non-response to labetalol (Sensitivity = 63%; FPR = 5%; AUC = 0.87; LHR(+) = 11.9). Non-response to labetalol for hypertensive crisis in pregnancy is correlated with a higher cardiovascular resistance index and lower gestational age. The recognition of a specific hemodynamic profile is crucial for tailoring personalised management of severe hypertension during pregnancy.

Authors

Institutions

Publication Details

Journal
Ultrasound in Obstetrics and Gynecology
Published
2024-09-01
DOI
https://doi.org/10.1002/uog.27998
Primary Topic
Birth, Development, and Health
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

OP15.07: Use of the cardiovascular resistance index to predict labetalol non‐response in the management of hypertensive crisis during pregnancy

J. Santelices, Elsa De La Cadena, Á. Sepúlveda‐Martínez, D. Jamett et al.
2 links
Ultrasound in Obstetrics and Gynecology
Birth, Development, and Health
article

OP15.07: Use of the cardiovascular resistance index to predict labetalol non‐response in the management of hypertensive crisis during pregnancy

J. Santelices, Elsa De La Cadena, Á. Sepúlveda‐Martínez, D. Jamett, C. Spatafore, M. Parra‐Cordero
article en

Abstract

To determine the role of hemodynamic and biophysical markers at hypertensive crisis to predict treatment failure with labetalol. This cohort study involved pregnancies with hypertensive crisis upon admission or during hospitalisation. Heart rate (HR), systolic (SBP), and diastolic blood pressure (DBP) were recorded before IV-labetalol administration. The cardiovascular resistance index (CVRI) was calculated as SBP/HR. Non-responders to labetalol were identified if maximum dose was reached or if a Caesarean section was required due to fetal distress during treatment. A hyperdynamic profile was defined as HR>90 and estimated fetal weight (EFW) >10th percentile. A high-resistance profile was characterised by EFW < 10th percentile or HR< 90. Responders and non-responders were compared using Mann-Whitney test. Time-to-response in both profiles was assessed using Cox regression and Kaplan-Meier curves. Finally, a multivariate logistic regression analysis was conducted to determine factors associated with therapeutic failure with beta-blockers. Out of the 44 pregnancies examined, 57% (n = 25) were identified as non-responders. Responders exhibited a higher incidence of the hyperdynamic profile compared to non-responders (26% vs. 4%; p = 0.03). Additionally, non-responders displayed a significantly higher CVRI compared to responders (2.27 [2.03-2.48] vs. 1.90 [1.47-2.14]; p = 0.002). Time-to-response was markedly shorter in the hyperdynamic profile group compared to the high-resistance profile (p < 0.05). Multivariate analysis revealed that lower gestational age, higher SBP, and lower HR were the most reliable predictors of non-response to labetalol (Sensitivity = 63%; FPR = 5%; AUC = 0.87; LHR(+) = 11.9). Non-response to labetalol for hypertensive crisis in pregnancy is correlated with a higher cardiovascular resistance index and lower gestational age. The recognition of a specific hemodynamic profile is crucial for tailoring personalised management of severe hypertension during pregnancy.

Ultrasound in Obstetrics and GynecologyVol. 64(S1)
Hospital Clínico de la Universidad de Chile (CL), Hospital San Borja Arriarán (CL), University of Chile (CL)
Openalex Percentile: Top 76%
Birth, Development, and Health
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.